Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway

Fig. 2

Characterization of HA-pGNR@MSN. A Structure of HA-pGNR@MSN. B Zeta potential assay of GNRs and various therapeutic nanocomposites. C Diameter distribution of GNRs and various therapeutic nanocomposites. D FT-IR spectra of GNRs, GNR@MSN, GNR@MSN-NH2, pGNR@MSN, and HA-pGNR@MSN. E N2 absorption–desorption isotherm of GNR@MSN and corresponding pore size distribution curve (inset). HA, hyaluronic acid; pGNR, polyethylene glycol-modified gold nanorod; MSN, mesoporous silica nanoparticle; FT-IR, Fourier transform infrared

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us